Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Cell Med
Main Authors: Naderi, Malihe, Gholipour, Naghmeh, Zolfaghari, Mohammad Reza, Moradi Binabaj, Maryam, Yegane Moghadam, Ahmad, Motalleb, Gholamreza
Formato: Artigo
Idioma:Inglês
Publicado em: Babol University of Medical Sciences 2014
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293608/
https://ncbi.nlm.nih.gov/pubmed/25635247
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados